Startup Scouting for Corporations
|
See Oxcan's full profile BOOK A DEMO |
| Headquarters United Kingdom |
Founded Year 2020 |
Total Funding
$1.7M |
Employees
11 - 50 |
Status Active |
About OxcanOxford Cancer Analytics Ltd is on a mission to realize curative cancer treatments through early detection. OXcan's machine learning platform enables minimally invasive and inexpensive cancer screening in high risk populations through analysing cancer materials shed into the blood. |
HeadquartersUnited Kingdom |
General Information on Oxcan
| Brand name | Oxcan |
| Company name | Oxford Cancer Analytics Ltd. |
| Website | https://www.oxcan.co.uk/ |
| Founded year | 2020 |
| Employees | 11 - 50 |
| Founding team | |
| Contact | [email protected] |
|
Find startup solutions in your specific business context The INNOSPOT Startup Discovery platform helps you to find the right startup solutions by leveraging the world's most powerful Startup Search Engine analyzing millions of data points.
|
BOOK A DEMO |
Recent News and Activity about Oxcan |
|
Sustainweb
•
01.04.2022
Sustain welcomes new member OXCANSustain's Council of Trustees have approved the Sustainable Food and Farming Working Group from the Oxford Climate Alumni Network ( OXCAN ) to join the Sustain alliance. Connecting with Oxford University alumni working on climate change, OXCAN is building a library of the most useful climate change information, links and latest research from Oxford, whilst their working groups are a chance for those with expertise or interest in a particular ... 
|
|
Business Leader - UK
•
06.09.2021
OXcan secures £1.28m in oversubscribed seed funding round | NewsOXcan (Oxford Cancer Analytics), a startup that uses machine learning and liquid biopsy for early lung cancer detection, recently raised £1.28M in an oversubscribed seed round and is now supported by Cancer Research UK, Civilisation Ventures, the Francis Crick Institute, Oxford Technology Management, and MegaRobo. Joining the international group of backers are business angels such as the Chief Digital Officer of T-Mobile USA, Marcus East, and ... 
|
|
Business Leader
•
06.09.2021
OXcan secures £1.28m in oversubscribed seed funding roundcancer detection, recently raised £1.28M in an oversubscribed seed round and is now supported by Cancer Research UK, Civilisation Ventures, the Francis Crick Institute, Oxford Technology Management, and MegaRobo.Joining the international group of backers are business angels such as the Chief Digital Officer of T-Mobile USA, Marcus East, and the former European President of GlaxoSmithKline, Brad Wilson.Every day in the UK, around 130 people are ...
|
Footer
About INNOSPOT
